Post

MGT 290-003 Biotechnology Industry Immersion
Winter 2019

Course Description

This course introduces students to the many facets of the biotechnology industry and provides a framework for understanding the complex forces that shape and drive it. Drawing upon the deep expertise of UC Davis as well as connections to industry experts, each session will take a deep dive into a challenging issue.

MBA and Ph.D. students will work in teams to analyze real problems in the biotech/pharma industry, then present possible solutions. The goal is to create knowledge, not just disseminate knowledge.

PhD students should contact Dr. Kjelstrom to receive permission to enroll.

Download Winter 2019 Syllabus

Instructor

Judith A. Kjelstrom, Director Emerita, UC Davis Biotechnology Program and Academic Coordinator, Graduate School of Management

Schedule

Week 1:  Friday, January 11, 2019

  Welcome and Orientation  
  An Introduction to Drug Development Lonnie Bookbinder, PhD, MBA, Founder and CEO, ARIZ Precision Medicine
  Case Study: Issues in growing a small company
 
Presented by Lonnie Bookbinder

Week 2:  Friday, January 18, 2019

  Case Study: Supply Chain Issues Charles Calderaro III, Senior VP, Global Manufacturing, Biomarin Pharmaceutical
  ​Case Study 3:  Issues Encountered when Expanding Partnerships or Markets (exact topic TBA) Steve Chamow, PhD, Principal, Chamow and Associates (Biopharmaceutical Product Development)

Week 3: Friday, January 25, 2019

  Case Study 4: Product Development using Data Informatics (exact title TBA) Kimberly Barnholt, PhD, Global Program Manager, Enhance Data & Insights Sharing, Genentech, Inc.
  Case Study 5:  Tips for Entrepreneurs (exact topic TBA; based on new article; Moleculera Labs Story: Lessons in a Capital Efficient Start-Up) Craig Shimasaki, PhD, MBA, President and CEO, Moleculera Labs and BioSource Consulting

Week 4: Friday, Feb 1, 2019

  Case Study 6: Marketing and Commercialization of Drugs and Products Omead Ostadan, MBA, VP of Products and Operations, Illumina, Inc.
  Case Study 7: What does it take to grow a small company? – Access to Financial Capital and Human Capital (access to talent, promotion of diversity), Creation of a corporate culture, etc.   Julie Cherrington, PhD, President and CEO, Arch Oncology, Inc.

Week 5: Friday, Feb 8, 2019

  Case Study 8:  Innovations in the Future – Precision Medicine using Big Data analytics Jeff Welser, PhD, VP and Lab Director, with Kristen Beck, PhD, Staff Scientist, IBM Research-Almaden
  Case Study 9: Innovations in the Future – Stem Cells and Targeted Therapies Christopher Murriel, PhD, Associate Director, Department of Cancer Biology, OncoMed Pharmaceuticals